1. Home
  2. RBKB vs NYXH Comparison

RBKB vs NYXH Comparison

Compare RBKB & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RBKB

Rhinebeck Bancorp Inc.

N/A

Current Price

$13.11

Market Cap

196.9M

Sector

Finance

ML Signal

N/A

Logo Nyxoah SA

NYXH

Nyxoah SA

N/A

Current Price

$1.56

Market Cap

165.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RBKB
NYXH
Founded
1860
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.9M
165.0M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
RBKB
NYXH
Price
$13.11
$1.56
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
100.4K
240.8K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
215.00
N/A
EPS
0.44
N/A
Revenue
$2,984,000.00
N/A
Revenue This Year
N/A
$213.98
Revenue Next Year
N/A
$126.25
P/E Ratio
$29.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.41
$1.26
52 Week High
$17.99
$6.87

Technical Indicators

Market Signals
Indicator
RBKB
NYXH
Relative Strength Index (RSI) 52.26 47.90
Support Level $11.63 $1.28
Resistance Level $16.55 $1.70
Average True Range (ATR) 0.22 0.09
MACD 0.14 0.00
Stochastic Oscillator 80.82 19.12

Price Performance

Historical Comparison
RBKB
NYXH

About RBKB Rhinebeck Bancorp Inc.

Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank, which is a New York-chartered stock savings bank. It provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management. The Bank's primary business activity is accepting deposits from the general public and using those funds together with borrowings, to originate commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and indirect automobile loans, and to purchase one- to four-family residential real estate loans and investment securities.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: